Equities
Health CarePharmaceuticals and Biotechnology
  • Price (DKK)428.40
  • Today's Change-1.00 / -0.23%
  • Shares traded506.65k
  • 1 Year change+6.38%
  • Beta0.5727
Data delayed at least 15 minutes, as of Sep 15 2026 16:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2025202520242023
OPERATIONS
Net income584306408
Depreciation/depletion597597186
Non-Cash items216197103
Cash taxes paid, supplemental185300106
Cash interest paid, supplemental667621
Changes in working capital(175)(80)(140)
Total cash from operations1,2221,020557
INVESTING
Capital expenditures(471)(360)(276)
Other investing and cash flow items, total(1500)160(10)
Total cash from investing(1971)(200)(286)
FINANCING
Financing cash flow items0(86)(4.16)
Total cash dividends paid(403)(250)(379)
Issuance (retirement) of stock, net(56)3822
Issuance (retirement) of debt, net1,212(405)107
Total cash from financing753(703)(254)
NET CHANGE IN CASH
Foreign exchange effects(8.6)13(7.38)
Net change in cash(4.7)13010
Net cash-begin balance/reserved for future use280150140
Net cash-end balance/reserved for future use275280150
SUPPLEMENTAL INCOME
Depreciation, supplemental597597186
Cash interest paid, supplemental667621
Cash taxes paid, supplemental185300106
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.